Search form
Search
contact us
Navigation
home
boards
job ratings
cp wire
medtech news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» bempedoic acid
bempedoic acid
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
Xconomy
Esperion Therapeutics
FDA
bempedoic acid
Flag link:
Esperion shifts to show not tell
Esperion shifts to show not tell
EP Vantage
Esperion Therapeutics
bempedoic acid
Nexletol
Flag link:
Esperion adds more competition to cholesterol drug market with newly approved drug
Esperion adds more competition to cholesterol drug market with newly approved drug
BioPharma Dive
Esperion Therapeutics
cholesterol
bempedoic acid
FDA
Nexletol
Flag link:
Migraine, cholesterol upstarts top the list of FDA decisions to watch this quarter
Migraine, cholesterol upstarts top the list of FDA decisions to watch this quarter
Fierce Pharma
FDA
migraines
cholesterol
Epizyme
tazemetostat
Esperion
bempedoic acid
teprotumumab
Horizon Therapeutics
Biohaven
rimegepant
Flag link:
Esperion's cholesterol-lowering drug clears test in diabetics
Esperion's cholesterol-lowering drug clears test in diabetics
Fierce Biotech
Esperion Therapeutics
type 2 diabetics
bempedoic acid
Flag link:
Here's Why Esperion Therapeutics Shares Rocketed 11.5% Higher Today
Here's Why Esperion Therapeutics Shares Rocketed 11.5% Higher Today
Motley Fool
Esperion Therapeutics
bempedoic acid
FDA
Flag link:
Experion’s Cholesterol Drug Looks Great in Phase III, but Faces Tough Market
Experion’s Cholesterol Drug Looks Great in Phase III, but Faces Tough Market
BioSpace
Esperion
clinical trials
bempedoic acid
American College of Cardiology
cholesterol
Flag link:
Esperion’s cholesterol-lowering pill works when statins fail
Esperion’s cholesterol-lowering pill works when statins fail
Pharmaforum
Esperion Therapeutics
cholesterol
statins
bempedoic acid
Flag link:
ACC 2019 preview – Bayer hopes for heart failure panache
ACC 2019 preview – Bayer hopes for heart failure panache
EP Vantage
Bayer
heart failure
Amarin
Esperion
ACC
Vascepa
bempedoic acid
Flag link:
What's Next for Esperion Therapeutics' Cholesterol-Lowering Drug
What's Next for Esperion Therapeutics' Cholesterol-Lowering Drug
Motley Fool
Esperion Therapeutics
bempedoic acid
cholesterol
Flag link:
A new drug lowers cholesterol. Can it spoil a multibillion-dollar market?
A new drug lowers cholesterol. Can it spoil a multibillion-dollar market?
Stat
Esperion Therapeutics
bempedoic acid
LDL cholesterol
Flag link:
Highly anticipated trial results expected soon could move all three of these biotechs
Highly anticipated trial results expected soon could move all three of these biotechs
Motley Fool
Sangamo Therapeutics
Esperion Therapeutics
Loxo Oncology
SB-913
bempedoic acid
LOXO-292
Flag link:
Esperion's Cholesterol Combo Pill Cuts Bad Cholesterol 35%
Esperion's Cholesterol Combo Pill Cuts Bad Cholesterol 35%
Forbes
Esperion Therapeutics
bempedoic acid
statins
Zetia
Merck
cholesterol
Flag link:
Esperion's LDL med aces a third pivotal trial
Esperion's LDL med aces a third pivotal trial
Fierce Biotech
Esperion Therapeutics
clinical trials
bempedoic acid
ASCVD
Flag link:
Esperion tumbles as patient deaths weigh on cholesterol drug
Esperion tumbles as patient deaths weigh on cholesterol drug
Biopharma Dive
Esperion Therapeutics
clinical trials
bempedoic acid
Flag link:
Esperion bolsters cholesterol drug with new combo data
Esperion bolsters cholesterol drug with new combo data
Biopharma Dive
Esperion Therapeutics
bempedoic acid
cholesterol
Flag link:
Esperion's cholesterol drug succeeds in late-stage study
Esperion's cholesterol drug succeeds in late-stage study
Reuters
Esperion Therapeutics
clinical trials
bempedoic acid
cholesterol
Flag link:
Esperion shares bounce up on an effective triplet approach to slashing LDL
Esperion shares bounce up on an effective triplet approach to slashing LDL
Endpoints
Esperion
LDL cholesterol
bempedoic acid
Zetia
Lipitor
Flag link:
If Esperion Wants to Market the Next Big Cholesterol Drug, It Will Take Strategy
If Esperion Wants to Market the Next Big Cholesterol Drug, It Will Take Strategy
Motley Fool
Esperion
bempedoic acid
cholesterol
Flag link:
Esperion beefs up late-stage cholesterol program
Esperion beefs up late-stage cholesterol program
BioPharma Dive
Esperion
bempedoic acid
Flag link: